Clinical trials
Hepatitis C trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 11 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| AbbVie | 3 |
| Kawin Technology Share-holding Co., Ltd. | 3 |
| The First Hospital of Jilin University | 3 |
| Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. | 2 |
| Gilead Sciences | 2 |
| Ginkgopharma CO., LTD | 2 |
| Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2 |
| Peking University People's Hospital | 2 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 39 |
| Hepatitis C, Chronic | 9 |
| Fibrosis | 4 |
| Hepatitis B | 4 |
| Coinfection | 3 |
| Hepatitis | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Drug Misuse | 2 |
| Liver Cirrhosis | 2 |
| Syphilis | 2 |
Trials
Showing 51 to 39 of 39. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.